D
LSL Pharma Group Inc. LSL.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 16.83M 14.67M 12.94M 11.63M 10.57M
Total Other Revenue -- -- -- -- --
Total Revenue 16.83M 14.67M 12.94M 11.63M 10.57M
Cost of Revenue 11.96M 10.17M 9.04M 8.71M 8.17M
Gross Profit 4.87M 4.50M 3.90M 2.92M 2.39M
SG&A Expenses 4.22M 4.18M 3.70M 3.48M 3.20M
Depreciation & Amortization -47.20K -47.20K -47.20K -48.50K -49.60K
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 16.13M 14.30M 12.69M 12.14M 11.32M
Operating Income 693.90K 370.40K 246.40K -507.70K -758.70K
Income Before Tax 2.50M 2.40M 2.38M -1.80M -2.09M
Income Tax Expenses 35.70K 35.70K 35.70K -- --
Earnings from Continuing Operations 2.46 2.36 2.35 -1.80 -2.09
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 2.46M 2.36M 2.35M -1.80M -2.09M
EBIT 693.90K 370.40K 246.40K -507.70K -758.70K
EBITDA 2.06M 1.48M 1.20M 266.40K 14.60K
EPS Basic 0.02 0.02 0.02 -0.02 -0.02
Normalized Basic EPS -0.01 -0.01 -0.01 -0.01 -0.02
EPS Diluted 0.02 0.02 0.02 -0.02 -0.03
Normalized Diluted EPS -0.01 -0.01 -0.01 -0.01 -0.02
Average Basic Shares Outstanding 462.07M 452.31M 421.36M 387.86M 355.21M
Average Diluted Shares Outstanding 462.27M 452.63M 421.67M 388.17M 355.33M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --